Panbela Announces Closing of Approximately $9.0 Million Public Offering Feb 1, 2024 07:00AM
Panbela Therapeutics (PBLA) Prices 4.375M Share Offering at $2.06/sh Jan 29, 2024 06:15AM
Panbela Announces Pricing of Approximately $9.0 Million Public Offering Jan 29, 2024 06:15AM
Panbela Therapeutics (PBLA) Enters 2.56M Share Private Placement at $0.78/sh, Exercises Warrants Dec 21, 2023 09:16AM
Panbela Therapeutics Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $2.0 Million Gross Proceeds Priced At-the-Market Dec 21, 2023 09:15AM


Nov 3, 2023 07:55AM Panbela Therapeutics (PBLA) Announces Exercise of Warrants and Issuance of New Warrants for $1.9M in Proceeds
Nov 3, 2023 07:55AM Panbela Therapeutics Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $1.9 Million Gross Proceeds Priced At-the-Market
Jun 21, 2023 04:15PM Panbela Announces Closing of Approximately $8.5 Million Public Offering
Jun 16, 2023 08:15AM Panbela Therapeutics Inc. (PBLA) Prices $8.5M Share and Warrant Offering at $3.75/sh
Jun 16, 2023 08:15AM Panbela Announces Pricing of Approximately $8.5 Million Public Offering
Feb 13, 2023 08:30AM Panbela Announces Closing of Approximately $15 Million Public Offering, and Regains Compliance with Nasdaq Listing Standards
Jan 31, 2023 10:07AM Roth Capital Resumes Panbella Therapeutics (PBLA) at Buy, PT $10
Jan 26, 2023 08:42AM Panbela Therapeutics Inc. (PBLA) Prices Approximately $15 Million Public Offering of Common Stock, Warrants
Jan 26, 2023 08:41AM Panbela Announces Pricing of Approximately $15 Million Public Offering
Jan 26, 2023 08:41AM Panbela Announces Pricing of Approximately $15 Million Public Offering
Sep 30, 2022 08:38AM Panbela Therapeutics Inc. (PBLA) Prices Approximately $6 Million Public Offering
Sep 30, 2022 08:37AM Panbela Announces Pricing of Approximately $6 Million Public Offering
Sep 30, 2022 08:37AM Panbela Announces Pricing of Approximately $6 Million Public Offering
Jun 28, 2021 02:13AM UPDATE: Roth Capital Starts Panbella Therapeutics (PBLA) at Buy